10 completed. 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 10 |
Follow Chemoradiation: new trials by email Literature Review of Chemoradiation trials Research Report on Chemoradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer PD-1 antibody, Chemoradiation, Albumin-Bound Paclitaxel - Esophagus Cancer, Chemoradiotherapy | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 35 | 2020-10-01 | 2025-05-30 |
| Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer Chemoradiotherapy, Ipilimumab, Nivolumab - Rectal Cancer | Phase 2 | Completed | Johannes Laengle, MD, PhD | 80 | 2020-06-01 | 2024-04-23 |
| Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer Nivolumab, Chemoradiation - Oropharynx Cancer | Phase 2 | Completed | UNICANCER | 62 | 2019-07-25 | 2025-03-04 |
| Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer Pembrolizumab, Brachytherapy, Cisplatin - Cervical Cancer | Phase 2 | Completed | Linda R Duska | 94 | 2017-02-09 | 2025-07-03 |
| Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) nab-Paclitaxel, Gemcitabine, Chemoradiation - Pancreatic Neoplasms | Phase 2 | Completed | Celgene | 107 | 2015-04-21 | 2019-03-20 |
| Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck Nelfinavir (Viracept®) 1250 mg, Chemoradiation - Head and Neck Squamous Cell Carcinoma | Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 18 | 2014-07-01 | 2023-07-25 |
| Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients gemcitabine, cisplatin, chemoradiation - Cancer of Cervix | Phase 2 | Completed | Professor Fernando Figueira Integral Medicine Institute | 50 | 2013-09-01 | 2015-10-16 |
| A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma Gemcitabine, Abraxane, FOLFIRINOX - Pancreatic Adenocarcinoma | Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 32 | 2013-04-01 | 2021-02-25 |
| Oxaliplatin and 5-FU Based Preoperative Chemoradiation Oxaliplatin, Chemoradiation, 5-FU - Rectal Cancer | Phase 2 | Completed | Oslo University Hospital | 109 | 2005-09-01 | 2016-09-29 |
| Chemoradiation for Bone Metastasis chemoradiation - Breast Cancer, Bone Metastasis | Phase 2 | Completed | Rabin Medical Center | 29 | 2004-05-01 | 2013-02-05 |
Rectal Neoplasms (2) · Uterine Cervical Neoplasms (2) · Breast Neoplasms (1) · Esophageal Neoplasms (1) · Oropharyngeal Neoplasms (1) · Pain (1) · Pancreatic Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Abramson Cancer Center at Penn Medicine (2) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Celgene (1) · Johannes Laengle, MD, PhD (1) · Linda R Duska (1) · Oslo University Hospital (1) · Professor Fernando Figueira Integral Medicine Institute (1) · Rabin Medical Center (1) · UNICANCER (1)
United States (4) · France (2) · Austria (1) · Brazil (1) · Canada (1) · China (1) · Israel (1) · Italy (1) · Norway (1) · Spain (1)
Alexander Lin, MD (1) · Linda Duska, MD (1) · Michael Bergmann, MD (1) · Peter O'Dwyer, MD (1) · Teng Jin Ong, MD (1) · Yulia Kundel, MD (1)
PMID 11398890, PMID 11886723, PMID 16585222, PMID 21166756, PMID 21444871, PMID 22137164, PMID 23874586, PMID 25624177, PMID 26205955, PMID 27461255, PMID 31122213, PMID 31953079, PMID 33581976, PMID 40844778, PMID 41570275
2018 (1), 2019 (1)